ID   ATX1_RAT                Reviewed;         789 AA.
AC   Q63540;
DT   06-DEC-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 156.
DE   RecName: Full=Ataxin-1;
DE   AltName: Full=Spinocerebellar ataxia type 1 protein homolog;
GN   Name=Atxn1; Synonyms=Sca1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8852664; DOI=10.1093/hmg/5.3.381;
RA   Gossen M., Schmitt I., Obst K., Wahle P., Epplen J.T., Riess O.;
RT   "cDNA cloning and expression of rsca1, the rat counterpart of the human
RT   spinocerebellar ataxia type 1 gene.";
RL   Hum. Mol. Genet. 5:381-389(1996).
CC   -!- FUNCTION: Chromatin-binding factor that repress Notch signaling in the
CC       absence of Notch intracellular domain by acting as a CBF1 corepressor.
CC       Binds to the HEY promoter and might assist, along with NCOR2, RBPJ-
CC       mediated repression. Binds RNA in vitro. May be involved in RNA
CC       metabolism. In concert with CIC and ATXN1L, involved brain development.
CC       {ECO:0000250|UniProtKB:P54253, ECO:0000250|UniProtKB:P54254}.
CC   -!- SUBUNIT: Homooligomer. Interacts with CIC. Interacts with ANP32A,
CC       PQBP1, UBQLN4, ATXN1L and USP7. Directly interacts with RBPJ; this
CC       interaction is disrupted in the presence of Notch intracellular domain.
CC       Competes with ATXN1L for RBPJ-binding. Found in a complex with CIC and
CC       ATXN1L. {ECO:0000250|UniProtKB:P54253, ECO:0000250|UniProtKB:P54254}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P54253}. Nucleus
CC       {ECO:0000250|UniProtKB:P54253}. Note=Colocalizes with USP7 in the
CC       nucleus. {ECO:0000250|UniProtKB:P54253}.
CC   -!- DOMAIN: The AXH domain is required for interaction with CIC.
CC       {ECO:0000250|UniProtKB:P54254}.
CC   -!- PTM: Ubiquitinated by UBE3A, leading to its degradation by the
CC       proteasome. {ECO:0000250|UniProtKB:P54254}.
CC   -!- PTM: Phosphorylation at Ser-749 increases the pathogenicity of proteins
CC       with an expanded polyglutamine tract. {ECO:0000250|UniProtKB:P54253}.
CC   -!- PTM: Sumoylation is dependent on nuclear localization and
CC       phosphorylation at Ser-749. It is reduced in the presence of an
CC       expanded polyglutamine tract. {ECO:0000250|UniProtKB:P54253}.
CC   -!- POLYMORPHISM: The rat poly-Gln region is very limited in comparison to
CC       human ATXN1 and is not polymorphic.
CC   -!- SIMILARITY: Belongs to the ATXN1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X91619; CAA62822.1; -; mRNA.
DR   RefSeq; NP_036858.1; NM_012726.2.
DR   AlphaFoldDB; Q63540; -.
DR   BMRB; Q63540; -.
DR   SMR; Q63540; -.
DR   STRING; 10116.ENSRNOP00000023140; -.
DR   iPTMnet; Q63540; -.
DR   PhosphoSitePlus; Q63540; -.
DR   PaxDb; 10116-ENSRNOP00000023140; -.
DR   ABCD; Q63540; 2 sequenced antibodies.
DR   Ensembl; ENSRNOT00000023140.5; ENSRNOP00000023140.2; ENSRNOG00000016998.5.
DR   Ensembl; ENSRNOT00055012805; ENSRNOP00055010206; ENSRNOG00055007647.
DR   Ensembl; ENSRNOT00060030375; ENSRNOP00060024532; ENSRNOG00060017739.
DR   Ensembl; ENSRNOT00065016363; ENSRNOP00065012420; ENSRNOG00065010152.
DR   GeneID; 25049; -.
DR   KEGG; rno:25049; -.
DR   AGR; RGD:3624; -.
DR   CTD; 6310; -.
DR   RGD; 3624; Atxn1.
DR   eggNOG; KOG4053; Eukaryota.
DR   GeneTree; ENSGT00390000005939; -.
DR   HOGENOM; CLU_019983_0_0_1; -.
DR   InParanoid; Q63540; -.
DR   OMA; HHQGGTH; -.
DR   OrthoDB; 2882425at2759; -.
DR   PhylomeDB; Q63540; -.
DR   TreeFam; TF350643; -.
DR   PRO; PR:Q63540; -.
DR   Proteomes; UP000002494; Chromosome 17.
DR   Bgee; ENSRNOG00000016998; Expressed in frontal cortex and 18 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0042405; C:nuclear inclusion body; ISS:UniProtKB.
DR   GO; GO:0016363; C:nuclear matrix; ISS:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0034046; F:poly(G) binding; ISS:UniProtKB.
DR   GO; GO:0008266; F:poly(U) RNA binding; ISS:UniProtKB.
DR   GO; GO:0031208; F:POZ domain binding; ISO:RGD.
DR   GO; GO:0003723; F:RNA binding; ISO:RGD.
DR   GO; GO:0008344; P:adult locomotory behavior; ISO:RGD.
DR   GO; GO:0007420; P:brain development; ISS:UniProtKB.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007612; P:learning; ISS:UniProtKB.
DR   GO; GO:0048286; P:lung alveolus development; ISO:RGD.
DR   GO; GO:0007613; P:memory; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0043569; P:negative regulation of insulin-like growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; IBA:GO_Central.
DR   GO; GO:0051168; P:nuclear export; ISS:UniProtKB.
DR   GO; GO:0060252; P:positive regulation of glial cell proliferation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0035176; P:social behavior; ISS:UniProtKB.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0008542; P:visual learning; ISO:RGD.
DR   InterPro; IPR020997; Ataxin-1_N.
DR   InterPro; IPR043404; ATAXIN1-like.
DR   InterPro; IPR003652; Ataxin_AXH_dom.
DR   InterPro; IPR036096; Ataxin_AXH_dom_sf.
DR   PANTHER; PTHR13392; ATAXIN 1; 1.
DR   PANTHER; PTHR13392:SF5; ATAXIN-1; 1.
DR   Pfam; PF12547; ATXN-1_C; 1.
DR   Pfam; PF08517; AXH; 1.
DR   SMART; SM00536; AXH; 1.
DR   SUPFAM; SSF102031; AXH domain; 1.
DR   PROSITE; PS51148; AXH; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm; DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; RNA-binding; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..789
FT                   /note="Ataxin-1"
FT                   /id="PRO_0000064753"
FT   DOMAIN          536..667
FT                   /note="AXH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00496"
FT   REGION          1..73
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          188..237
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          296..397
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          468..578
FT                   /note="Self-association"
FT                   /evidence="ECO:0000250|UniProtKB:P54253"
FT   REGION          512..789
FT                   /note="Interaction with USP7"
FT                   /evidence="ECO:0000250|UniProtKB:P54253"
FT   REGION          514..740
FT                   /note="RNA-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P54253"
FT   REGION          736..772
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           768..771
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:P54254"
FT   COMPBIAS        212..237
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        310..328
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        343..387
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        739..764
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         81
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P54254"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P54253"
FT   MOD_RES         213
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P54253"
FT   MOD_RES         217
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P54254"
FT   MOD_RES         228
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P54254"
FT   MOD_RES         749
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P54253"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250|UniProtKB:P54253"
FT   CROSSLNK        193
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250|UniProtKB:P54253"
FT   CROSSLNK        583
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250|UniProtKB:P54253"
FT   CROSSLNK        670
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250|UniProtKB:P54253"
FT   CROSSLNK        719
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250|UniProtKB:P54253"
SQ   SEQUENCE   789 AA;  83501 MW;  AFA042249BAC99FE CRC64;
     MKSNQERSNE CLPPKKREIP ATSRPSEEKA TALPSDNHCV EGVAWLPSTP GSRGHGGGRH
     GPAGTSGEHG LQGMGLHKAL SAGLDYSPPS APRSVPTANT LPTVYPPPQS GTPVSPVQYA
     HLSHTFQFIG SSQYSGPYAG FIPSQLISPP GNPVTSAVAS AAGATTPSQR SQLEAYSTLL
     ANMGSLSQAP GHKVEPPPQQ HLGRAAGLVN PGSPPPTQQN QYIHISSSPQ SSGRATSPPI
     PVHLHPHQTM IPHTLTLGPS SQVVVQYSDA GGHFVPREST KKAESSRLQQ AMQAKEVLNG
     EMEKSRRYGA SSSVELSLGK TSSKSVPHPY ESRHVVVHPS PADYSSRDTS GVRGSVMVLP
     NSSTPSADLE TQQATHREAS PSTLNDKSGL HLGKPGHRSY ALSPHTVIQT THSASEPLPV
     GLPATAFYAG AQPPVIGYLS SQQQAITYAG GLPQHLVIPG TQPLLIPVGS PDMDTPGAAS
     AIVTSSPQFA AVPHTFVTTA LPKSENFNPE ALVTQAAYPA MVQAQIHLPV VQSVASPAAA
     SPTLPPYFMK GSIIQLANGE LKKVEDLKTE DFIQSAEISN DLKIDSSTVE RIEDSHSPGV
     AVIQFAVGEH RAQVSVEVLV EYPFFVFGQG WSSCCPERTS QLFDLPCSKL SVGDVCISLT
     LKNLKNGSVK KGQPVDPASA LLKHAKTDSL AGSRHRYAEQ ENGINQGSAQ VLSENGELKF
     PEKIGLPAAP FLTKIEPSKP TATRKRRWSA PETRKLEKSE DEPPLTLPKP SLIPQEVKIC
     IEGRSNVGK
//
